发明名称 PHARMACEUTICAL COMPOSITIONS CONTAINING CLOSTRIDIUM DIFFICILE TOXOIDS A AND B
摘要 This invention relates to compositions including Clostridium difficile toxins and/or toxoids and corresponding methods. The compositions of the invention include one or more excipients that increase stability and/or decrease aggregation of the toxins.
申请公布号 US2016317640(A1) 申请公布日期 2016.11.03
申请号 US201615083428 申请日期 2016.03.29
申请人 Sanofi Pasteur Biologics, LLC 发明人 MIDDAUGH C. Russell;FAHRNER Richard;CIARAMETARO Peter
分类号 A61K39/08;A61K47/08;A61K47/12;A61K47/26 主分类号 A61K39/08
代理机构 代理人
主权项 1. A method of inducing an immune response to Clostridium difficile in a subject, the method comprising administering to the subject a composition comprising a toxin or a toxoid of C. difficile and one or more pharmaceutically acceptable excipients, wherein the one or more pharmaceutically acceptable excipients increases thermal stability of the toxin or toxoid and/or reduces or delays aggregation of the toxin or toxoid, relative to a composition lacking the one or more pharmaceutically acceptable excipients.
地址 Cambridge MA US